uniQure N.V. - Ordinary Shares - Çeyreklik Nakit Akışı (NASDAQ:QURE) | MetaTrader

Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Toplam varlıklar 556.54 M605.4 M584.89 M888.38 M824.91 M778.71 M Toplam yükümlülükler 563.29 M571.72 M588.89 M659.64 M626.01 M629.36 M Toplam özsermaye -6.75 M33.69 M-4 M228.75 M198.9 M149.34 M Toplam yükümlülükler ve hissedarların özsermayesi 556.54 M605.4 M584.89 M888.38 M824.91 M778.71 M Toplam borç 51.32 M51.59 M51.84 M51.88 M49.7 M49.94 M Net borç 51.32 M51.59 M-325.3 M-642.42 M-573.15 M-536.9 M

Haberler

uniQure: Why A Shifting FDA Could Change Everything For AMT-130 (NASDAQ:QURE)

Biotech Investors Are Tuning Out the MAHA Chaos

uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates

uniQure, Huntington tedavisi için İngiltere’ye başvuracak

Kyverna Therapeutics: 'Strong Buy' On Additional POC Of Miv-Cel In Myasthenia Gravis

Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com

Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

A Unique Situation For UniQure (QURE)

Mizuho, FDA liderlik değişikliği sonrası uniQure hissesini yükseltti

Mizuho upgrades uniQure stock rating on FDA leadership change